Skip to main navigation Skip to search Skip to main content

Abstract

The management of food allergy is complicated by the lack of highly predictive biomarkers for diagnosis and prediction of disease course. The measurement of food-specific IgE is a useful tool together with clinical history but is an imprecise predictor of clinical reactivity. The gold standard for diagnosis and clinical research is a double-blind placebo-controlled food challenge. Improvement in our understanding of immune mechanisms of disease, development of high-throughput technologies, and advances in bioinformatics have yielded a number of promising new biomarkers of food allergy. In this review, we will discuss advances in immunoglobulin measurements, the utility of the basophil activation test, T-cell profiling, and the use of -omic technologies (transcriptome, epigenome, microbiome, and metabolome) as biomarker tools in food allergy.

Original languageEnglish
Pages (from-to)2516-2524
Number of pages9
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume8
Issue number8
DOIs
StatePublished - Sep 2020

Keywords

  • Basophil activation test
  • Biomarker
  • Components
  • Double-blind placebo-controlled food challenge (DBPCFC)
  • Epigenome
  • Epitopes
  • Metabolome
  • Microbiome
  • T-cell receptor repertoire
  • Transcriptome

Fingerprint

Dive into the research topics of 'Emerging Food Allergy Biomarkers'. Together they form a unique fingerprint.

Cite this